Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis

Blood Cancer J. 2020 Feb 17;10(2):18. doi: 10.1038/s41408-020-0285-6.

Authors

Gregorio Barilà¹, Laura Bonaldi², Angela Grassi², Annalisa Martines², Albana Liço¹, Nadia Macrì², Silvia Nalio², Laura Pavan¹, Tamara Berno¹, Antonio Branca¹, Giulia Calabretto¹, Marilena Carrino¹, Antonella Teramo¹, Sabrina Manni¹, Francesco Piazza¹, Gianpietro Semenzato¹, Renato Zambello³

Affiliations

¹ Department of Medicine (DIMED), Hematology and Clinical Immunology section, Padua University School of Medicine, Padua, Italy.
² Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.
³ Department of Medicine (DIMED), Hematology and Clinical Immunology section, Padua University School of Medicine, Padua, Italy. r.zambello@unipd.it.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers, Tumor / genetics
Chromosome Aberrations*
Chromosomes, Human / genetics*
Diploidy*
Female
Follow-Up Studies
Humans
In Situ Hybridization, Fluorescence / methods*
Karyotyping / methods*
Male
Multiple Myeloma / classification*
Multiple Myeloma / genetics*
Multiple Myeloma / pathology
Prognosis
Retrospective Studies
Survival Rate

Substances

Biomarkers, Tumor